Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BENEFIT 11 long-term follow-up study in clinically isolated syndrome and multiple sclerosis
2012-005262-35Phase 4Completed
- Sponsor
- Bayer
- Start
- Feb 2013
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of interferon beta-1b in clinically isolated syndrome (CIS), multiple sclerosis (MS), sponsored by Bayer. Started Feb 2013; status: completed.
02
Drugs
interferon beta-1b
03
Conditions
clinically isolated syndrome (CIS)multiple sclerosis (MS)
Beyond the preview
Go deeper on 2012-005262-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005262-35.